BioPharma México es donde expertos como Pide Un Deseo México vienen para network, aprender del otro, y discutir los desarrollos recientes en la industria biofarmacéutica.

Una Entrevista con Projecto Pide un Deseo México Presidente David Peña

David Peña es Presidente de Pali y Toto Piden un Deseo, ac, del Proyecto Pide un Deseo México, iap y de FEMEXER, todas ellas instituciones encargadas de atender enfermos con padecimientos extremadamente raros y de altísimo costo. Obtuvo su Licenciatura en Ciencias Políticas y Administración Pública en la Facultad de Ciencias Políticas y Sociales, UNAM y un Diplomado en Ciencias …

tcs, drug safety, genomics, technology, world drug safety congress europe

Re-imagining Drug Safety

Re-imaginging Drug Safety: Powered by Genomics, Information Integration & Emerging Technologies by Debashis Ghosh, President – Life Science, Manufacturing and Energy, Tata Consultancy Services The video covers: Changing context Genomics and drug safety Information and insights integration Next generation drug safety architecture using emerging technologies Regulatory direction Putting it all together For more information on Drug Safety, join us at the …

pharma, patient, engagement

In an age of integration and patient centricity what opportunities do these present for pharma?

Edition 4 of the “Insights on digital pharma” series tackled this question with answers from our DigiPharm 2013 attendees. Watch the video or find snippets from their interviews below. Tim Ringrose, CEO, Networks in Health “The opportunity for integration is to be able to really get true value out of all these new channels, alongside traditional channels- patient engagement is …

The Stem Cells Regenerative Medicine Congress is where experts like Russell Marians of LABS Inc meet to network, learn from each other, and discuss the latest stem cells strategies and technology.

LABS Inc on ensuring successful scale-up manufacturing

We were glad to have Russell Marians, Senior Scientist and Manager of Molecular and Cellular Biology at LABS Inc., present at the Stem Cells & Regenerative Medicine Congress in 2013. You can now download his presentation slides and video from the event, where he addresses how a winning assay development strategy is critical to ensure successful scale-up manufacturing. Download the presentation …

Stem Cells Regenerative Medicine Congress is where experts like Neuralstem's Richard Garr meet to network, learn from each other, and discuss the latest stem cell strategies and technology.

Neuralstem’s Richard Garr on Optimizing and Increasing Titer

We were excited to have Richard Garr, Chief Executive Officer of Neuralstem, at last year’s Stem Cells Regenerative Medicine Congress. Richard gave a presentation on optimizing and increasing titer in early stage clinical trials for an easier approval process as part of the event that focused on next generation approaches. Other speakers that participated in that section of the event …

Stem Cells USA is where experts like Scimitar Equity's Henry McCusker gather to network, learn from each other, and discuss the latest stem cells strategies and technology.

Scimitar Equity’s Henry McCusker at Stem Cells USA 2013

We were excited to have Scimitar Equity’s Founder and Director of Research Henry McCusker give the opening remarks at last year’s Stem Cells & Regenerative Medicine Congress USA. Henry not only opened up the conference, but also participated in a panel later on in the event. The panel session was titled “Capital formation strategies for stem cell and regenerative medicine …